Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ121112140,75
KB122912300,00
PKN105102-1,71
Msft3,28
Nokia5,7585,760,00
IBM-0,76
Mercedes-Benz Group AG57,9758,090,00
PFE-1,72
26.01.2026 9:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 23.01.2026 17:35:11
Victrex PLC (VCTX.L, London)
Poslední obchod Změna (%) Změna (GBP) Objem obchodů (GBP)
7,39 0,00 0,00 2 399 677
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 26.01.2026
Popis společnosti
Obecné informace
Název společnostiVictrex plc
TickerVCT
Kmenové akcie:Ordinary Shares
RICVCTX.L
ISINGB0009292243
Poslední známé roční výsledky30.09.2025
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 30.09.2025 1 169
Akcie v oběhu k 31.12.2025 87 071 124
MěnaGBP
Kontaktní informace
UliceVictrex Technology Centre
MěstoTHORNTON CLEVELEYS
PSČFY5 4QD
ZeměUnited Kingdom
Kontatní osobaAndrew Hanson
Funkce kontaktní osobyDirector - Investor Relations, Corporate Communications and ESG
Telefon441 253 897 700
Fax441253897701
Kontatní telefon441 253 898 121

Business Summary: Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), transport and electronics markets. The Medical segment is focused on implantable and non-implantable medical markets. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited, and Juvora Limited.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2025, Victrex plc revenues increased less than 1% to L296.4M. Net income increased 62% to L27.8M. Revenues reflect Medical segment increase of 11% to L58.8M, Americas segment increase of 3% to L74.9M, United Kingdom segment increase of 65% to L5.1M, also reflect Sustainable Solutions segment decrease of 2% to L233.9M, Europe, Middle East and Africa(EMEA) segment decrease of 3% to L124.5M.
Odvětvová klasifikace
TRBC2009Chemicals - Specialty
TRBC2012Specialty Chemicals (NEC)
RBSS2004Chemicals - Specialty
MGINDUSTRYChemicals - Plastics & Rubber
MGSECTORBasic Materials
NAICSPlastics Material and Resin Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Plastics Material & Resins Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Plastics Material and Resin Manufacturing
NAICS1997Offices of Other Holding Companies
SICPlastics Materials And Resins
SICHolding Companies, Nec



  • Poslední aktualizace: 26.01.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorJames Routh5101.01.202601.01.2026
Chief Financial Officer, Executive DirectorIan Melling-04.07.202204.07.2022
General Counsel, Company SecretaryJane Brisley-
Executive DirectorJakob Sigurdsson6101.01.202601.10.2017